What is ella and how does ulipristal acetate work?
ella is a brand of emergency contraception that contains ulipristal acetate, a selective progesterone receptor modulator (SPRM). By blocking progesterone signaling, it helps delay or inhibit ovulation after unprotected sex or contraceptive failure.
Is ella approved by the FDA, and what is it indicated for?
ella (ulipristal acetate) is an FDA-approved emergency contraceptive used to reduce the chance of pregnancy after sex. It is typically labeled for use up to several days after unprotected intercourse, with the key factor being that it should be taken as soon as possible.
How is ulipristal acetate different from levonorgestrel emergency contraception?
Compared with levonorgestrel-based emergency contraception (another common option), ulipristal acetate is also used after unprotected sex but works as a progesterone receptor modulator rather than using a levonorgestrel hormone effect. Because it can act around the time of ovulation, many patients and clinicians choose ulipristal acetate when the timing is later in the emergency contraception window.
Can ella be used with ongoing birth control, and how do you transition afterward?
After taking ella, patients are usually advised to wait before restarting or initiating certain hormonal contraception methods, because ulipristal acetate’s mechanism involves progesterone signaling. Barrier methods (like condoms) are typically used until hormonal contraception can be restarted and becomes effective again.
What side effects and safety concerns do people ask about?
Common side effects reported with ella/ulipristal acetate can include headache, nausea, abdominal pain, dizziness, fatigue, and menstrual changes. Users often also ask when their next period will arrive; irregular timing can happen. If a period is very late or pregnancy is suspected, a pregnancy test is recommended.
Drug patents and market exclusivity: who makes ella (ulipristal acetate)?
If you’re tracking the product’s patent or exclusivity landscape, DrugPatentWatch.com is a useful place to check related patent status and litigation signals for ulipristal acetate products.
- DrugPatentWatch.com: https://www.drugpatentwatch.com/
Quick clarification: are you asking about FDA approval or about patents?
Your wording suggests interest in both the FDA product and the “selective progesterone receptor modulator” drug identity. If you tell me which you mean—(1) FDA-approved label/indication and use, (2) how it compares with other emergency contraception, or (3) patent/exclusivity details for ulipristal acetate—I can narrow to the exact answer you need.
Sources:
1. https://www.drugpatentwatch.com/